Mayo Clinic December 9, 2021
John Halamka

The medical Internet of Things is filled with many valuable devices–and a few questionable ones. It’s critically important to separate clinically validated tools from marketing hype.

By John Halamka, M.D., president, Mayo Clinic Platform, and Paul Cerrato, senior research analyst and communications specialist, Mayo Clinic Platform

When William Shakespeare penned the words “All that glitters is not gold,” it’s unlikely he had the Internet of Things (IoT) in mind. And yet that truism perfectly describes the situation many clinicians and patients find themselves in as they attempt to choose reliable remote monitoring tools. The potential pitfall is well illustrated by a recent warning letter sent by the US Food and Drug Administration (FDA) to an IoT device vendor making unsubstantiated...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Digital Health, Health IT, IoT (Internet of Things), Patient / Consumer, Provider, Technology, Telehealth
Healthcare IoT security buyers shift focus from tools to measurable outcomes
Outcomes Drive IoT Security, KLAS Finds
KLAS Healthcare IoT Security 2026: Top Vendors Rated for Risk Reduction and ROI
Cost-Effective IoT-Based Real-Time Vital Sign Monitoring: An Affordable Telehealth Solution
IoT, AI To Drive Smart Hospital Management Systems

Share Article